Skip to content
Research Article Open access CC BY 4.0

Leveraging Digital Transformation for Enhanced Risk Mitigation and Compliance in Pharma Manufacturing

P. Ullagaddi

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 75–86 · Published 24 Jun 2024

10.9734/jamps/2024/v26i6697

Abstract

As the pharmaceutical manufacturing industry embraces digital transformation, innovative technologies are being adopted to improve risk management and regulatory compliance. The present study investigates the application of artificial intelligence, machine learning, the Internet of Things, and advanced data analytics in this sector. Integrating these technologies is essential for tackling product quality, patient safety, and operational efficiency challenges. Although the potential benefits are significant, there is a scarcity of comprehensive studies on the implementation and impact of digital technologies, specifically in the context of risk management and regulatory compliance within pharmaceutical manufacturing. The current study aims to address this gap by exploring how digital technologies can be utilized to enable real-time monitoring, predictive maintenance, proactive quality control, and streamlined regulatory compliance processes. Through a systematic literature review and analysis of case studies, best practices, challenges, and strategies for successful digital transformation in the pharmaceutical manufacturing industry are examined. The results emphasize the remarkable potential of digital technologies to enhance risk management, ensure regulatory compliance, and drive operational excellence. The central message conveyed is that embracing digital transformation is crucial for pharmaceutical companies to maintain competitiveness, mitigate risks, and deliver high-quality, safe medicines to patients. Furthermore, the necessity for collaboration between industry stakeholders and regulators to promote innovation while upholding rigorous quality and safety standards is highlighted.

Digital technologies pharmaceutical manufacturing risk management regulatory compliance advanced manufacturing techniques

Cited by 16

Industry 4.0 in Pharmaceuticals: A New Era of Smart Manufacturing

Muhammad Hammad, Manos Panaousis, Hassan Ali · Springer Series in Advanced Manufacturing · 2025

Converging Technologies In Pharma: A Review On The Integration Of Blockchain, AI, IoT And Data Analytics For A Digitally Transformed Industry

Pidakaala Shamyuktha, Prof Dr. A. Krishna Manjari Pawar · International Journal of Research Publication and Reviews · 2025

Multi-sector Workforce Development with Population-level Prevention

Jason Fruth, Carmen Irving, Andrea Fechner · International Journal of Health Sciences (IJHS) · 2024

Emerging Digital Innovations in Pharmaceutical Manufacturing Quality: A Systematised Review

Laura Fitzgerald, Eleni Niarchou, Ian Jones · Journal of Pharmaceutical Innovation · 2025

Cross-Regional Analysis of Global AI Healthcare Regulation

Pravin Ullagaddi · Journal of Computer and Communications · 2025

A Framework for Cloud Validation in Pharma

Pravin Ullagaddi · Journal of Computer and Communications · 2024

The Role of Productization in End-To-End Traceability

Janne Harkonen, Javier Mauricio Guerrero Rodriguez, Erno Mustonen · Eng · 2024

Showing 12 of 16 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

16

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.